The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
by The Investment U Research Team
It’s going to be a bumpy week.
With the prospect of General Motors (NYSE: GM) going into bankruptcy June 1, lighting up the news wires, citizens and investors alike have lots to be emotional about. From being angry about pensions to upset over executive compensation, there’s lots of fuel for this fire.
We know that emotion doesn’t always bode well for logical outcomes, but it can equate to some above average profits if you can keep your wits about you.
The market has been on a tear recently, up for 23 sessions in the longest run-up since 1933. But that doesn’t mean much. We could be primed for a pullback. Some negative earnings reports at the right time this week is all it would take to send the markets sharply downward.
When that happens, look to pick up some bargains as many companies retest lows seen last month. Unfortunately, no one knows when, or if, it’ll happen. It could be this week – it could be next month. But the point is that it won’t make any different if you’re not ready for it.
For example, Bank of America (NYSE: BAC) plummeted down to a low of $2.53 over the last 45 days – it’s already over 300% higher. When the largest of the large caps get pushed down to unreasonable lows, they’re bound to bounce back.
It’s why you need to keep an eye on the over-reactions and market emotion in the coming weeks. It spells a nice return for those who are waiting for the next major index’s stumble.
Companies mentioned in this article: GM and BAC.
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed